DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Microbial and immune faecal determinants in infants hospitalized with COVID-19 reflect bifidobacterial dysbiosis and immature intestinal immunity
The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread rapidly worldwide, seriously endangering human health. Although SARS-CoV-2 had a lower impact on paediatric population, children with COVID-19 have been reported as suffering from gastrointestinal (GI) symptoms at a higher rate than adults. The aim of this work was to evaluate faeces as a source of potential biomarkers of severity in the paediatric population, with an emphasis on intestinal microbiota and faecal immune mediators, trying to identify possible dysbiosis and immune intestinal dysfunction associated with the risk of hospitalization. This study involved 19 patients with COVID-19 under 24 months of age hospitalized during the pandemic at 6 different hospitals in Spain, and it included a comparable age-matched healthy control group (n = 18). Patients and controls were stratified according to their age in two groups: newborns or young infants (from 0 to 3 months old) and toddlers (infants from 6 to 24 months old). To characterize microbial intestinal communities, sequencing with Illumina technology of total 16S rDNA amplicons and internal transcribed spacer (ITS) amplicons of bifidobacteria were used. Faecal calprotectin (FC) and a range of human cytokines, chemokines, and growth factors were measured in faecal samples using ELISA and a multiplex system. Significant reduction in the abundance of sequences belonging to the phylum Actinobacteria was found in those infants with COVID-19, as well as in the Bifidobacteriaceae family. A different pattern of bifidobacteria was observed in patients, mainly represented by lower percentages of Bifidobacterium breve, as compared with controls. In the group of hospitalized young infants, FC was almost absent compared to age-matched healthy controls. A lower prevalence in faecal excretion of immune factors in these infected patients was also observed., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. This word was funded in part by a CSIC (Consejo Superior de Investigaciones Científicas) internal project PIE reference 202070E237. The research was also funded by the European Commission-Next Generation EU (REGULATION EU 2020/2094), through CSIC’s Global Health Platform (PTI Salud Global). I. G-D. has a grant FJC2021-047052-I financed by MCIN/AEI/10.13039/501100011033 and by European Union “NextGenerationEU/PRTR.” Grant AYUDA-20201-50910 from the Government of Asturias Principality (FICYT, supported by FEDER) is also received., Peer reviewed
Proyecto:
AEI FJC2021-047052-I
DOI: http://hdl.handle.net/10261/347528, https://api.elsevier.com/content/abstract/scopus_id/85167333796
HANDLE: http://hdl.handle.net/10261/347528, https://api.elsevier.com/content/abstract/scopus_id/85167333796